| |
| Issue |
Title |
| |
| Vol 19, No 2 (2025) |
Comparison of muscle magnetic resonance imaging data with clinical and laboratory parameters in follow-up of patients with idiopathic inflammatory myopathy |
Abstract
PDF (Rus)
|
|
A. A. Kolomeyichuk, L. P. Ananyeva, A. N. Helkovskaya-Sergeeva, A. D. Koltakova, L. V. Ptichkina, D. O. Kazakov |
| |
| Vol 19, No 2 (2025) |
Assessment of antiphospholipid antibodies using enzyme-linked immunosorbent assay and chemiluminescent method |
Abstract
PDF (Rus)
PDF (Eng)
|
|
T. M. Reshetnyak, M. V. Cherkasova, F. A. Cheldieva, K. S. Nurbaeva, A. M. Lila |
| |
| Vol 19, No 2 (2025) |
Use of olokizumab, a direct interleukin 6 inhibitor, in the treatment of rheumatoid arthritis: real-world evidence |
Abstract
PDF (Rus)
PDF (Eng)
|
|
P. A. Shesternya, A. I. Zagrebneva, O. V. Antipova, Yu. V. Arbuzova, I. G. Bannikova, L. V. Belozertseva, E. A. Bogdanova, S. A. Bykova, E. A. Vasilenko, I. B. Vinogradova, S. Yu. Davidyan, O. E. Epifanova, E. V. Zemerova, M. V. Zlobin, L. V. Ivanova, N. A. Ilyina, L. V. Ilyushina, E. P. Klyuchnikova, A. V. Makevnina, E. R. Myasoutova, E. E. Nakonechnaya, A. B. Pavlova, T. V. Plaksina, A. V. Rybin, T. S. Salnikova, L. V. Solodovnikova, A. V. Fedorova, I. A. Cherencova, E. V. Jakovleva, S. P. Yakupova, E. N. Alekseev, A. M. Lila |
| |
| Vol 19, No 2 (2025) |
Comorbid infections in patients with ANCA-associated systemic vasculitis: a prospective cohort study |
Abstract
PDF (Rus)
|
|
M. A. Litvinova, N. M. Bulanov, P. I. Novikov, J. Zhao, D. Munblit, S. V. Moiseev |
| |
| Vol 19, No 2 (2025) |
On the application of the “treat-to-target” strategy and the identification of a cohort of difficult-to-treat patients with rheumatoid arthritis in real-world clinical practice |
Abstract
PDF (Rus)
|
|
O. V. Teplyakova, L. P. Evstigneeva, T. S. Petukhova, E. O. Dolishnaya |
| |
| Vol 19, No 2 (2025) |
Clinical features of systemic lupus erythematosus in men depending on testosterone level |
Abstract
PDF (Rus)
|
|
T. S. Panevin, T. V. Popkova, E. G. Zotkin, S. I. Glukhova, M. E. Diatroptov |
| |
| Vol 19, No 2 (2025) |
Comorbid pathology in patients with late-stage ankylosing spondylitis |
Abstract
PDF (Rus)
|
|
E. S. Yushina, E. V. Zonova, E. B. Luksha, D. N. Orlov, V. V. Rerikh, V. N. Koksharova |
| |
| Vol 19, No 2 (2025) |
The efficacy of colchicine in patients with gout with different missense genetic variants of the ABCG2 gene (V12M; rs2231137 and Q141K; rs2231142) |
Abstract
PDF (Rus)
|
|
M. S. Eliseev, M. N. Chikina, I. A. Guseva, O. V. Zhelyabina, Ya. I. Kuzmina |
| |
| Vol 19, No 2 (2025) |
The efficacy of a complex of vitamins B 1, B6 and B 12 in combination with nonsteroidal antiinflammatory drugs for pain control in osteoarthritis: meta-analysis of randomized controlled trials |
Abstract
PDF (Rus)
|
|
E. S. Filatova, A. E. Karateev, S. I. Glukhova, A. M. Lila |
| |
| Vol 19, No 2 (2025) |
The dose of febuxostat required to achieve the target level of uric acid in patients with normal and impaired renal function |
Abstract
PDF (Rus)
|
|
M. S. Eliseev, M. N. Chikina, O. V. Zhelyabina, Ya. I. Kuzmina |
| |
| Online First |
Pharmacogenetic aspects of the effectiveness of nonsteroidal anti-inflammatory drugs and opioids for postoperative pain management in patients after total joint arthroplasty |
Abstract
PDF (Rus)
|
|
A. S. Zhiryakova, N. P. Denisenko, S. N. Tuchkova, A. S. Petrukhina, A. V. Kryukov, I. V. Sychev, K. B. Mirzaev, O. V. Averkov, V. I. Vechorko, E. O. Filatov, D. A. Sychev |
| |
| Online First |
Efficacy and safety of olokizumab in the treatment of rheumatoid arthritis in real clinical practice in Kazakhstan |
Abstract
PDF (Rus)
|
|
G. A. Togizbayev, D. I. Parpiyeva, D. A. Maksot |
| |
| Vol 19, No 1 (2025) |
Experience of using the interleukin-6 inhibitor olokizumab in patients with rheumatoid arthritis in real-life clinical practice (based on data from Tyumen Regional Rheumatology Center) |
Abstract
PDF (Rus)
|
|
I. M. Patrikeeva, Yu. A. Lushpaeva, N. V. Knaub, E. A. Ustinova, O. A. Belikov, M. B. Dolgikh, T. Yu. Malysheva |
| |
| Vol 19, No 1 (2025) |
Psychological characteristics of patients with rheumatoid arthritis with severe anxiety and depression |
Abstract
PDF (Rus)
|
|
I. N. Abrosimov, V. M. Yaltonsky, T. A. Lisitsyna, A. A. Abramkin, E. I Lamcheva, A. Yu. Timashkov, A. M. Lila |
| |
| Vol 19, No 1 (2025) |
Is fibromyalgia secondary to rheumatic diseases? |
Abstract
PDF (Rus)
|
|
E. G. Filatova, N. A. Melikova, E. S. Filatova, A. M. Lila |
| |
| Vol 19, No 1 (2025) |
Efficacy of divozilimab in the treatment of systemic sclerosis: results of the randomized phase III clinical trial BCD-132-5/LIBERIUS |
Abstract
PDF (Rus)
PDF (Eng)
|
|
L. P. Ananyeva, M. N. Starovoytova, I. Z. Gaydukova, G. V. Lukina, E. V. Zonova, L. V. Eliseeva, G. F. Fatkhullina, D. I. Abdulganieva, D. G. Krechikova, T. V. Kropotina, O. B. Nesmeyanova, I. B. Vinogradova, E. S. Zhugrova, L. V. Ivanova, N. E. Nikulenkova, O. R. Ziganshin, T. V. Plaksina, M. V. Zlobin, Yu. Yu. Grabovetskaya, N. F. Soroka, O. B. Ershova, T. V. Povarova, O. N. Anoshenkova, A. A. Lutsky, A. V. Zinkina-Orikhan, Yu. N. Linkova, E. A. Fokina, A. A. Porozova, A. V. Eremeeva |
| |
| Vol 19, No 1 (2025) |
Assessment of muscle damage using magnetic resonance imaging data in dermatomyositis and sporadic inclusion body myositis |
Abstract
PDF (Rus)
|
|
A. A. Kolomeychuk, L. P. Ananyeva, L. V. Ptichkina, A. N. Khelkovskaya-Sergeeva, D. O. Kazakov |
| |
| Vol 19, No 1 (2025) |
The association between genetic characteristics and treatment failure when switching from biologic disease-modifying antirheumatic drugs/Janus kinase inhibitors in patients with rheumatoid arthritis |
Abstract
PDF (Rus)
PDF (Eng)
|
|
A. O. Bobkova, A. M. Lila, A. E. Karateev, I. A. Guseva, E. Yu. Samarkina, M. V. Shabatina, N. V. Konovalova, D. A. Varlamov |
| |
| Vol 19, No 1 (2025) |
Body composition and skeletal muscles status in patients with rheumatoid arthritis during treatment with biologic disease-modifying antirheumatic drugs |
Abstract
PDF (Rus)
|
|
O. V. Dobrovolskaya, M. V. Kozyreva, N. V. Demin, A. Yu. Feklistov, N. V. Toroptsova |
| |
| Vol 19, No 1 (2025) |
New possibilities for the treatment of systemic lupus erythematosus. How much does the effect cost? |
Abstract
PDF (Rus)
|
|
E. A. Pyadushkina, A. M. Lila, E. E. Yagnenkova, V. I. Ignatyeva, E. V. Derkach |
| |
| Vol 18, No 6 (2024) |
Dynamics of laboratory markers of endothelial dysfunction in patients with psoriatic arthritis under the influence of the interleukin-17A inhibitor netakimab |
Abstract
PDF (Rus)
|
|
A. V. Petrov, O. A. Pritulo, A. A. Petrov |
| |
| Vol 18, No 6 (2024) |
Characteristics of the new coronavirus infection (COVID-19) in patients with systemic sclerosis |
Abstract
PDF (Rus)
|
|
M. N. Starovoytova, O. V. Desinova, L. P. Ananieva, O. A. Koneva, L. А. Garzanova, O. B. Ovsyannikova, R. U. Shayakhmetova |
| |
| Vol 18, No 6 (2024) |
Possibilities of transposition of the extensores carpi tendons in the treatment of the rheumatoid hand |
Abstract
PDF (Rus)
|
|
A. V. Rozov, E. I. Byalik, A. M. Lila |
| |
| Vol 18, No 6 (2024) |
Results of a non-interventional multicenter observational study on the diagnosis and treatment of patients with axial psoriatic arthritis in rea-world clinical practice in the Russian Federation (NiSaXPA) |
Abstract
PDF (Rus)
|
|
T. V. Korotaeva, E. E. Gubar, E. Yu. Loginova, Yu. L. Korsakova, E. A. Vasilenko, I.-D. Yu. Ilyevsky, L. V. Ivanova, E. Yu. Akulinushkina, P. А. Shesternya, O. V. Matveychuk, Yu. Yu. Grabovetskaya, A. A. Barakat, M. A. Korolev, E. V. Zonova, O. A. Georginova, I. V. Kolotilina, I. M. Marusenko, I. B. Vinogradova, O. B. Nesmeyanova, N. E. Grigoriadi, A. V. Petrov, D. G. Krechikova, T. V. Kropotina, S. P. Yakupova, V. I. Mazurov |
| |
| Vol 18, No 6 (2024) |
Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment |
Abstract
PDF (Rus)
|
|
Eugen Feist, Roy M. Fleischmann, Saeed Fatenejad, Daria Bukhanova, Sergey Grishin, Sofia Kuzkina, Michael Luggen, Evgeniy Nasonov, Mikhail Samsonov, Josef S. Smolen |
| |
| Vol 18, No 6 (2024) |
Comparative study of the clinical efficacy of the first domestic bioanalogue of tocilizumab based on the results of a randomized clinical trial of phase III |
Abstract
PDF (Rus)
|
|
E. V. Akatova, Yu. S. Bakhareva, O. V. Bugrova, I. B. Vinogradova, E. V. Gerasimova, Yu. E. Drevina, O. B. Ershova, E. V. Zonova, Yu. I. Ivanova, E. P. Ilivanova, M. M. Kostik, D. G. Krechikova, D. A. Kusevich, A. L. Maslyansky, A. D. Meshkov, N. S. Mosesova, K. A. Nagornova, D. V. Nosovich, S. A. Polyakova, T. A. Popova, E. A. Smolyarchuk, V. N. Sorotskaya, Yu. G. Shvarts, L. N. Shilova, M. S. Shostak, I. Yu. Yunonin, N. E. Akhtyamova-Givirovskaya, R. A. Khamitov, O. A. Markova, E. I. Zagoruiko, E. V. Zuev |
| |
| Vol 18, No 6 (2024) |
Results of a three-year observation of the course of non-radiological axial spondyloarthritis |
Abstract
PDF (Rus)
|
|
Yu. Yu. Grabovetskaya, A. V. Smirnov, M. V. Cherkasova, A. A. Rudneva, A. M. Lila |
| |
| Vol 18, No 6 (2024) |
Association between the HLA-A, HLA-B, HLA-C and HLA-DRB1 gene alleles and Sjögren's syndrome with anti-Ro/SSA and anti-La/SSB autoantibodies production |
Abstract
PDF (Rus)
|
|
I. A. Guseva, M. D. Chanyshev, A. V. Torgashina, N. V. Vlasenko, Yu. I. Khvan, E. Yu. Samarkina, M. V. Shabatina, K. F. Khafizov |
| |
| Vol 18, No 6 (2024) |
Serum calprotectin in Behcet's disease |
Abstract
PDF (Rus)
|
|
K. S. Nurbaeva, M. V. Cherkasova, R. G. Goloeva, A. M. Lila, T. M. Reshetnyak |
| |
| Vol 18, No 5 (2024) |
Clinical and immunologic abnormalities in COVID-19 |
Abstract
PDF (Rus)
|
|
A. K. Karibova, S. S. Akhmedkhanov, M. T. Kudae, H. M. Malaev |
| |
| Vol 18, No 5 (2024) |
Investigation of the analgesic efficacy of local therapy with non-steroidal anti-inflammatory drugs in patients with knee osteoarthritis |
Abstract
PDF (Rus)
|
|
E. A. Strebkova, E. A. Taskina, N. G. Kashevarova, E. P. Sharapova, N. M. Savushkina, T. A. Korotkova, L. I. Alekseeva, A. M. Lila |
| |
| Vol 18, No 5 (2024) |
Switching from interleukin-6 receptor inhibitors to the direct interleukin-6 inhibitor olokizumab in patients with rheumatoid arthritis: efficacy and safety during one year of therapy |
Abstract
PDF (Rus)
|
|
P. A. Shesternya, A. A. Baranov, I. B. Vinogradova, O. N. Anoshenkova, O. V. Antipova, E. A. Bogdanova, Yu. Yu. Grabovetskaya, E. P. Ilivanova, A. N. Kalyagin, A. A. Blinova, N. A. Lapkina, M. V. Mokrousova, O. B. Nesmeyanova, N. M. Nikitina, N. V. Yudina, E. N. Alekseev, E. L. Nasonov, A. M. Lila |
| |
| Vol 18, No 5 (2024) |
Efficacy and safety of the biosimilar etanercept in the treatment of patients with rheumatoid arthritis and spondyloarthritis |
Abstract
PDF (Rus)
|
|
B. G. Issayeva, D. S. Dilmanova, A. S. Amanzholova, S. M. Issayeva, A. B. Kanapina, A. E. Turtaeva, G. Sh. Trimova |
| |
| Vol 18, No 5 (2024) |
Clinical characteristics of patients with chronic post-traumatic pain: data from a prospective study |
Abstract
PDF (Rus)
|
|
A. A. Bialik, A. E. Karateev, M. A. Makarov, V. А. Nesterenko, V. E. Bialik, E. I. Bialik |
| |
| Vol 18, No 5 (2024) |
Clinical and instrumental characteristics of osteoarthritis in hyperuricemia |
Abstract
PDF (Rus)
|
|
E. A. Taskina, A. M. Lila, L. I. Alekseeva, N. G. Kashevarova, K. M. Mikhailov, A. R. Halmetova, E. A. Strebkova, E. P. Sharapova, N. M. Savushkina, D. M. Kudinskiy, T. A. Raskina, I. B. Vinogradova |
| |
| Vol 18, No 5 (2024) |
Difficult-to-treat psoriatic arthritis. Data from the All-Russian registry of patients with psoriatic arthritis |
Abstract
PDF (Rus)
|
|
E. Yu. Loginova, T. V. Korotaeva, E. E. Gubar, Yu. L. Korsakova, E. L. Nasonov |
| |
| Vol 18, No 5 (2024) |
Comparative analysis of the frequency of comorbid diseases in axial psoriatic arthritis and other variants of axial spondyloarthritis. Data from a hospital cohort |
Abstract
PDF (Rus)
|
|
A. A. Yanushonite, Yu. L. Korsakova, T. V. Korotaeva, E. E. Gubar, E. Yu. Loginova, M. M. Urumova, A. E. Dimitreva, S. I. Glukhova |
| |
| Vol 18, No 5 (2024) |
Pharmacoeconomic analysis of rituximab and belimumab therapy in patients with systemic lupus erythematosus |
Abstract
PDF (Rus)
|
|
D. A. Gerasimova, V. A. Gontarenko, E. V. Gerasimova, O. V. Zakharova, L. А. Lobuteva, T. V. Popkova, A. M. Lila |
| |
| Vol 18, No 5 (2024) |
Ultrasonography of the salivary glands in Sjögren's disease: own data analysis |
Abstract
PDF (Rus)
PDF (Eng)
|
|
Yu. I. Khvan, A. V. Torgashina, A. V. Volkov, S. I. Glukhov |
| |
| Vol 18, No 5 (2024) |
"Atherosclerotic" phenotype of rheumatoid arthritis. What do we know about it? |
Abstract
PDF (Rus)
|
|
A. V. Gordeev, E. V. Matyanova, E. V. Pozhidaev, E. G. Zotkin, A. M. Lila |
| |
| Vol 18, No 4 (2024) |
Serum calprotectin in vasculitis associated with antineutrophil cytoplasmic antibodies |
Abstract
PDF (Rus)
PDF (Eng)
|
|
E. N. Vorkel, T. M. Reshetnyak, K. S. Nurbaeva, M. V. Cherkasova, G. M. Tarasova, O. N. Egorova, A. M. Lila |
| |
| Vol 18, No 4 (2024) |
Multifunctional protein nucleobindin 1 as a marker of vascular damage in systemic lupus erythematosus |
Abstract
PDF (Rus)
PDF (Eng)
|
|
A. O. Mikhailina, O. S. Kostareva, E. A. Aseeva, S. I. Glukhova, A. M. Lila, S. V. Tishchenko |
| |
| Vol 18, No 4 (2024) |
Long-term multicenter observational study of the drug Alflutop in Russia: use in patients with knee osteoarthritis (report 4) |
Abstract
PDF (Rus)
|
|
E. A. Taskina, L. I. Alekseeva, N. G. Kashevarova, A. M. Lila |
| |
| Vol 18, No 4 (2024) |
Netakimab for the treatment of psoriatic arthritis: 3-year results of the phase III BCD-085-8/PATERA study |
Abstract
PDF (Rus)
|
|
T. V. Korotaeva, V. I. Mazurov, A. M. Lila, I. Z. Gaidukova, A. L. Bakulev, A. V. Samtsov, V. R. Khairutdinov, A. V. Zinkina-Orikhan, Yu. N. Linkova, A. V. Eremeeva |
| |
| Vol 18, No 4 (2024) |
Validation of the Russian-language version of Ankylosing Spondylitis Quality of Life (ASQoL) questionnaire |
Abstract
PDF (Rus)
|
|
L. D. Vorobyova, T. V. Dubinina, A. O. Sablina, A. B. Demina, E. V. Ilinykh, K. V. Sakharova, I. A. Andrianova, T. V. Korotaeva, L. V. Ivanova |
| |
| Vol 18, No 4 (2024) |
The influence of type 2 diabetes mellitus on clinical manifestations of osteoarthritis |
Abstract
PDF (Rus)
|
|
E. A. Taskina, L. I. Alekseeva, N. G. Kashevarova, E. A. Strebkova, E. P. Sharapova, N. M. Savushkina, K. M. Mikhailov, T. A. Raskina, I. B. Vinogradova, E. N. Otteva, E. V. Zonova, O. N. Anoshenkova, A. M. Lila |
| |
| Vol 18, No 4 (2024) |
Evaluation of the efficacy of high molecular weight hyaluronic acid with chondroitin sulfate in post-traumatic knee osteoarthritis |
Abstract
PDF (Rus)
|
|
E. I. Bialik, M. A. Makarov, V. A. Nesterenko, V. E. Bialik, A. E. Karateev, A. A. Bialik, V. I. Stadnik |
| |
| Vol 18, No 4 (2024) |
Characteristics of clinical manifestations and pharmacotherapy in patients with rheumatoid arthritis requiring switching between biologic disease-modifying antirheumatic drugs and Janus kinase inhibitors |
Abstract
PDF (Rus)
PDF (Eng)
|
|
A. O. Bobkova, A. M. Lila, A. E. Karateev |
| |
| Vol 18, No 4 (2024) |
Clinical and instrumental characteristics of axial psoriatic arthritis in combination with hyperuricemia |
Abstract
PDF (Rus)
|
|
Yu. L. Korsakova, L. D. Vorobyeva, E. E. Gubar, E. Yu. Loginova, P. O. Tremaskina, T. V. Korotaeva, A. E. Dimitreva, M. M. Urumova |
| |
| Vol 18, No 3 (2024) |
Results of a 24-week open-label, non-interventional study on the efficacy and safety of olokizumab therapy in patients with rheumatoid arthritis after switching from anti-B-cell therapy during the SARS-CoV-2 pandemic |
Abstract
PDF (Rus)
PDF (Eng)
|
|
A. V. Fedorova, N. E. Banshchikova, A. E. Sizikov, A. A. Mullagaliev, E. A. Letyagina, A. A. Akimova, N. A. Ilyina, Yu. D. Kurochkina, Yu. B. Ubshaeva, V. O. Omelchenko, O. A. Chumasova, N. S. Shkaruba, M. A. Korolev |
| |
| Vol 18, No 3 (2024) |
Efficacy and safety of levilimab in the treatment of rheumatoid arthritis in real-life clinical practice: first results of the HELIOS observational study |
Abstract
PDF (Rus)
|
|
A. M. Lila, I. Z. Gaydukova, O. N. Anoshenkova, I. G. Bannikova, I. B. Vinogradova, M. L. Goldman, S. Yu. Davidian, L. P. Evstigneeva, O. E. Epifanova, E. V. Zemerova, A. I. Zagrebneva, L. V. Ivanova, A. K. Karibova, I. V. Menshikova, O. N. Mironenko, M. P. Mikhailova, N. E. Nikulenkova, I. M. Patrikeeva, T. V. Plaksina, G. R. Savvina, R. R. Samigullina, L. E. Sarantseva, J. V. Usacheva, O. P. Ukhanova, G. F. Fatkhullina, A. L. Chudinov, I. A. Shafieva, S. P. Yakupova |
| |
| Vol 18, No 3 (2024) |
Survival and lethal outcomes in Orenburg population of patients with systemic lupus erythematosus |
Abstract
PDF (Rus)
PDF (Eng)
|
|
N. V. Lazareva, O. V. Bugrova, N. E. Artemova, K. A. Nagornova |
| |
| Vol 18, No 3 (2024) |
Osteosarcopenia in women with rheumatoid arthritis: association with nutritional status and physical condition |
Abstract
PDF (Rus)
|
|
O. V. Dobrovolskaya, A. Yu. Feklistov, N. V. Demin, M. V. Kozyreva, N. V. Toroptsova |
| |
| Vol 18, No 3 (2024) |
Efficacy of low molecular weight hyaluronic acid (500–730 kDa) in post-traumatic pathology of periarticular soft tissues at different sites: data from an open-label pilot clinical study |
Abstract
PDF (Rus)
|
|
V. A. Nesterenko, M. A. Makarov, A. E. Karateev, E. I. Bialik, V. E. Bialik, A. A. Bialik |
| |
| Vol 18, No 3 (2024) |
The development of postoperative pain in patients with late-stage knee osteoarthritis is associated with impaired metabolism and transport of fatty acids in blood cells |
Abstract
PDF (Rus)
PDF (Eng)
|
|
E. B. Chetina, G. A. Markova, K. E. Glemba, M. A. Makarov |
| |
| Vol 18, No 3 (2024) |
Olokizumab in patients with inflammatory phenotype of osteoarthritis, treatment experience |
Abstract
PDF (Rus)
PDF (Eng)
|
|
A. M. Lila, L. I. Alekseeva, E. A. Taskina, N. G. Kashevarova, E. P. Sharapova, E. A. Strebkova, N. M. Savushkina, A. R. Khalmetova, V. A. Nesterenko, A. S. Avdeeva, E. Yu. Samarkina, M. E. Diatroptov, O. G. Alekseeva |
| |
| Vol 18, No 2 (2024) |
Alfacalcidol in clinical practice: focus on the efficacy and safety of the Russian generic drug |
Abstract
PDF (Rus)
|
|
N. V. Toroptsova, M. V. Kozyreva, O. V. Dobrovolskaya |
| |
| Vol 18, No 2 (2024) |
Efficacy and safety of the type I interferon receptor inhibitor anifrolumab in patients with systemic lupus erythematosus (results of a 6-month study) |
Abstract
PDF (Rus)
|
|
T. M. Reshetnyak, E. A. Aseeva, A. A. Shumilova, N. Yu. Nikishina, S. I. Glukhova, S. Yu. Shkireeva, A. M. Lila |
| |
| Vol 18, No 2 (2024) |
CINCA/NOMID is a rare autoinflammatory syndrome in rheumatological practice. Experience of diagnosis, management and therapy with interleukin-1 inhibitors |
Abstract
PDF (Rus)
|
|
S. O. Salugina, E. S. Fedoro, A. V. Torgashina |
| |
| Vol 18, No 2 (2024) |
Comparative analysis of the efficacy of seniprutug (BCD-180) and adalimumab in the treatment of active radiographic axial spondyloarthritis: results of a systematic review and matching-adjusted indirect comparison |
Abstract
PDF (Rus)
|
|
A. M. Lila, T. V. Dubinina, D. G. Tolkacheva, K. V. Sapozhnikov, N. A. Sableva, M. A. Morozova, P. S. Pukhtinskaia |
| |
| Vol 18, No 2 (2024) |
Results of a non-interventional multicenter study of management of patients with non-radiological axial spondyloarthritis in real-life clinical practice in the Russian Federation (NiSpAR) |
Abstract
PDF (Rus)
|
|
T. V. Dubinina, A. M. Lila, E. V. Kvasova, E. M. Agafonova, I. A. Andrianova, L. V. Ivanova, D. V. Yurk, N. A. Garaeva, E. Y. Akulinushkina, A. N. Vedekhina, I. B. Bashkova, S. A. Lapshina, Y. Y. Grabovetskaya, N. F. Semenova, M. I. Valkova, D. G. Krechikova, O. S. Mazhaeva, I. B. Vinogradova, O. V. Bugrova, S. M. Voloshenko, G. R. Enikeeva, E. S. Immis, L. F. Timasheva, E. E. Biserova, L. Z. Shaimukhametova, I. M. Patrikeeva, A. A. Barakat, P. A. Shesternya, N. M. Nikitina, M. I. Yupatova, O. N. Anoshenkova, M. A. Korolev, Y. B. Ubshaeva, E. A. Vasilenko, E. V. Zonova, O. B. Nesmeyanova, E. A. Bogdanova, V. I. Mazurov, R. R. Samigullina, I. M. Marusenko |
| |
| Vol 18, No 2 (2024) |
Is there a “renal-pulmonary syndrome” in rheumatoid arthritis? |
Abstract
PDF (Rus)
|
|
A. V. Gordeev, E. A. Galushko, E. V. Matyanova, E. V. Pozhidaev, E. G. Zotkin, A. M. Lila |
| |
| Vol 18, No 2 (2024) |
Evaluation of the efficacy of complex analgesic therapy, including a combination of B vitamins, in patients with combination of osteoarthritis and chronic non-specific low back pain (results of an open-label pilot clinical trial) |
Abstract
PDF (Rus)
|
|
E. S. Filatova, A. E. Karateev, E. L. Shakhramanova, D. A. Ghukasyan, S. Yu. Shkireeva, A. M. Lila |
| |
| Vol 18, No 1 (2024) |
Mixed connective tissue disease with juvenile onset: results of a retrospective single-center study |
Abstract
PDF (Rus)
PDF (Eng)
|
|
M. I. Kaleda, I. P. Nikishina, A. N. Latypova, N. N. Yudkina, Zh. G. Verizhnikova, A. N. Shapovalenko, T. N. Pachkoria |
| |
| Vol 18, No 1 (2024) |
Alflutop Russian longitudinal multicenter observational study: use in patients with chronic back pain (message 3) |
Abstract
PDF (Rus)
|
|
A. M. Lila, A. E. Karateev, L. I. Alexeeva, E. A. Taskina, An. B. Danilov, S. A. Zhivolupov, I. N. Samartsev, E. R. Barantsevich, A. P. Rachin |
| |
| Vol 18, No 1 (2024) |
Inflammatory and neutrophil activation markers in Behcet's disease |
Abstract
PDF (Rus)
|
|
K. S. Nurbaeva, T. M. Reshetnyak, R. G. Goloeva, A. M. Lila, E. L. Nasonov |
| |
| Vol 18, No 1 (2024) |
Association of a high rate of glycolysis and the activity of the uncoupling of oxidation and phosphorylation in the blood cells of patients with late-stage knee osteoarthritis and the development of postoperative pain |
Abstract
PDF (Rus)
|
|
E. B. Chetina, G. A. Markova, K. E. Glemba, M. A. Makarov |
| |
| Vol 18, No 1 (2024) |
Glucocorticoid toxicity index in patients with systemic lupus erythematosus (preliminary data) |
Abstract
PDF (Rus)
PDF (Eng)
|
|
E. V. Ermolaeva, E. A. Aseeva, N. Yu. Nikishina, T. V. Popkova, A. M. Lila |
| |
| Vol 18, No 1 (2024) |
Long-term efficacy and safety of netakimab in patients with active ankylosing spondylitis: results of three years of use in the international multicentre, randomized, double-blind, phase III clinical trial BCD-085-5/ASTERA |
Abstract
PDF (Rus)
|
|
V. I. Mazurov, Sh. F. Erdes, I. Z. Gaydukova, T. V. Dubinina, A. M. Pristrom, E. V. Kunder, N. F. Soroka, A. A. Kastanayan, T. V. Povarova, E. S. Zhugrova, T. V. Plaksina, P. A. Shesternya, T. V. Kropotina, O. V. Antipova, E. A. Smolyarchuk, O. A. Tsyupa, D. I. Abdulganieva, S. A. Lapshina, D. G. Krechikova, I. G. Gordeev, O. B. Nesmeyanova, E. P. Ilivanova, A. V. Strelkova, V. V. Tyrenko, E. A. Mikhailova, A. V. Eremeeva |
| |
| Vol 18, No 1 (2024) |
Analysis of clinical manifestations and spectrum of pharmacotherapy in Moscow and St. Petersburg cohorts of patients with adult-onset Still's disease |
Abstract
PDF (Rus)
PDF (Eng)
|
|
K. E. Zotkina, A. V. Torgashina, V. Yu. Myachikova, A. L. Maslyansky |
| |
| Vol 18, No 1 (2024) |
Peculiarities of pharmacotherapy of patients with rheumatoid arthritis associated with interstitial lung disease |
Abstract
PDF (Rus)
|
|
A. V. Gordeev, E. A. Galushko, E. V. Matyanova, E. V. Pozhidaev, E. G. Zotkin, A. M. Lila |
| |
| Vol 17, No 6 (2023) |
Long-term effects of netakimab on health-related quality of life, back pain and work productivity in patients with ankylosing spondylitis: results of the international, multicentre, randomized double-blind phase III clinical trial BCD-085-5/ASTERA |
Abstract
PDF (Rus)
|
|
T. V. Dubinina, A. B. Demina, E. M. Agafonova, Sh. F. Erdes, V. I. Mazurov, I. Z. Gaydukova, A. M. Pristrom, E. V. Kunder, N. F. Soroka, A. A. Kastanayan, T. V. Povarova, E. S. Zhugrova, T. V. Plaksina, P. A. Shesternya, T. V. Kropotina, O. V. Antipova, E. A. Smolyarchuk, O. A. Tsyupa, D. I. Abdulganieva, S. A. Lapshina, D. G. Krechikova, I. G. Gordeev, O. B. Nesmeyanova, V. V. Tyrenko, E. P. Ilivanova, A. V. Strelkova |
| |
| Vol 17, No 6 (2023) |
The use of hepcidin as a marker for diagnosing the type of anemia in patients with high activity of rheumatoid arthritis |
Abstract
PDF (Rus)
|
|
A. S. Semashko, A. M. Lila, E. A. Galushko, A. V. Gordeev, E. G. Zotkin |
| |
| Vol 17, No 6 (2023) |
How Russian patients with rheumatoid arthritis assess their condition: initial data from the OPTIMA (Patient Assessment of Severity, Outcomes and Medical Care in Arthritis) pilot study |
Abstract
PDF (Rus)
|
|
A. E. Karateev, E. Yu. Polishchuk, H. R. Makhmudov, N. A. Bulgakova, E. S. Filatova, A. S. Potapova, V. N. Amirdzhanova, A. M. Lila |
| |
| Vol 17, No 6 (2023) |
Efficacy and safety of the Gam-COVID-Vac in patients with immunoinflammatory rheumatic diseases: preliminary data of prospective study |
Abstract
PDF (Rus)
|
|
A. N. Kulikov, N. V. Muravyeva, B. S. Belov, G. I. Gridneva, E. S. Aronova |
| |
| Vol 17, No 6 (2023) |
Trends in large joint total arthroplasty in patients with rheumatic diseases: an experience of a specialized department of traumatology and orthopedics |
Abstract
PDF (Rus)
|
|
I. G. Kushnareva, M. A. Makarov, A. E. Karateev, A. I. Gorelova |
| |
| Vol 17, No 6 (2023) |
Evaluation of the impact of a course of therapy with an injectable form of chondroitin sulfate on the duration of remission and quality of life in patients with osteoarthritis |
Abstract
PDF (Rus)
|
|
P. S. Kovalenko, I. S. Dydykina, O. G. Alekseeva, E. L. Shakhramanova, A. S. Potapova, S. I. Glukhova, E. G. Zotkin |
| |
| Vol 17, No 6 (2023) |
Search for predictors of achieving minimal disease activity during tofacitinib therapy in patients with psoriatic arthritis |
Abstract
PDF (Rus)
|
|
L. D. Vorobyova, T. V. Korotaeva, S. I. Glukhova, E. Yu. Loginova, E. E. Gubar, Yu. L. Korsakova |
| |
| Vol 17, No 6 (2023) |
Dissociation of clinical symptoms and magnetic resonance imaging data in axial psoriatic arthritis |
Abstract
PDF (Rus)
|
|
A. O. Vasilieva, D. E. Filipenko, E. V. Kapustina, N. V. Popov, P. A. Shesternya |
| |
| Vol 17, No 6 (2023) |
Factors associated with achieving an acceptable health-related quality of life in the treatment of patients with psoriatic arthritis |
Abstract
PDF (Rus)
PDF (Eng)
|
|
P. O. Tremaskina, T. V. Korotaeva, E. Yu. Loginova, S. I. Glukhova, A. M. Lila |
| |
| Vol 17, No 6 (2023) |
Portrait of a patient with systemic lupus erythematosus for the prescription of the type I interferon inhibitor anifrolumab |
Abstract
PDF (Rus)
PDF (Eng)
|
|
T. M. Reshetnyak, E. A. Aseeva, A. A. Shumilova, N. Yu. Nikishina, S. Yu. Shkireeva, A. M. Lila |
| |
| Vol 17, No 6 (2023) |
Results of a non-interventional observational multicenter study of the management of patients with axial psoriatic arthritis in real-life clinical practice (NiSaXPA) |
Abstract
PDF (Rus)
|
|
T. V. Korotaeva, E. E. Gubar, E. Yu. Loginova, Y. L. Korsakova, E. A. Vasilenko, I.-D. Yu. Ilyevsky, L. V. Ivanova, E. Yu. Akulinushkina, P. A. Shesternya, O. V. Matveychuk, Yu. Yu. Grabovetskaya, A. A. Barakat, M. A. Korolev, E. V. Zonova, O. A. Georginova, I. V. Kolotilina, I. M. Marusenko, I. B. Vinogradova, O. B. Nesmeyanova, N. E. Grigoriadi, A. V. Petrov, D. G. Krechikova, T. V. Kropotina, S. P. Yakupova, V. I. Mazurov |
| |
| Vol 17, No 5 (2023) |
Efficacy and safety of the combined use of celecoxib, diacerein and a combination of glucosamine and chondroitin for the control of musculoskeletal pain associated with osteoarthritis and nonspecific back pain |
Abstract
PDF (Rus)
|
|
A. E. Karateev, E. Yu. Polishchuk, A. M. Lila, A. N. Ananyev, L. V. Ananyeva, A. V. Bondarev, A. A. Bondareva, A. R. Bukanbaeva, S. V. Vorster, S. A. Gadzhieva, D. G. Danilov, R. I. Eliseev, I. S. Zabelin, M. Yu. Ignatenko, I. V. Itkina, A. E. Kolesnikov, M. Yu. Konoplyanskaya, Yu. G. Krasnoyarova, S. I. Kukushkin, V. A. Lila, O. V. Makareva, V. S. Myagkikh, I. V. Nelgovskaya, N. V. Ocheredko, R. A. Panov, I. A. Polyakov, A. S. Prozorov, S. S. Rubina, M. E. Ryabochkina, M. A. Takhaev, E. R. Tokareva, T. V. Tolbina, M. I. Fominykh, V. V. Tsarev, E. I. Sharipova, M. V. Sheven, G. I. Shcherbakov, S. A. Yanchenkova |
| |
| Vol 17, No 5 (2023) |
Adverse events that occurred in patients with rheumatoid arthritis during long-term follow-up |
Abstract
PDF (Rus)
|
|
I. S. Dydykina, P. O. Postnikova, P. S. Kovalenko, S. I. Glukhova, A. M. Lila |
| |
| Vol 17, No 5 (2023) |
Renal function during long-term therapy with rituximab in patients with systemic sclerosis |
Abstract
PDF (Rus)
|
|
M. N. Starovoitova, O. V. Desinova, L. P. Ananyeva, O. A. Koneva, L. A. Garzanova, O. B. Ovsyannikova, R. U. Shayakhmetova |
| |
| Vol 17, No 5 (2023) |
Clinical picture of ankylosing spondylitis in HLA-B27 positive and negative patients |
Abstract
PDF (Rus)
|
|
Sh. F. Erdes, K. V. Sakharova |
| |
| Vol 17, No 5 (2023) |
Chronic hepatitis B in hospitalized rheumatologic patients: problems of screening and reactivation of infection |
Abstract
PDF (Rus)
|
|
G. I. Gridneva, E. S. Aronova, B. S. Belov |
| |
| Vol 17, No 5 (2023) |
Urate-lowering therapy and the risk of developing type 2 diabetes mellitus in patients with gout (results of a prospective study) |
Abstract
PDF (Rus)
|
|
M. S. Eliseev, O. V. Zhelyabina |
| |
| Vol 17, No 5 (2023) |
Results of a clinical study of Traumeel® S and Zeel® T in patients with knee osteoarthritis and concomitant cardiovascular disease |
Abstract
PDF (Rus)
|
|
L. I. Alekseeva, V. I. Mazurov, E. V. Zonova, O. B. Ershova, O. V. Reshetko |
| |
| Vol 17, No 5 (2023) |
Comparison of colorimetric and electrochemical (Easy Touch GCU Meter) methods for determination of blood uric acid in clinical practice in patients with gout and hyperuricemia (data from a pilot study) |
Abstract
PDF (Rus)
|
|
M. S. Eliseev, E. V. Panina, O. V. Zheliabina |
| |
| Vol 17, No 5 (2023) |
Evaluation of efficacy and safety of combined use of nonsteroidal anti-inflammatory drugs and extended release tolperisone in patients with ankle injuries |
Abstract
PDF (Rus)
|
|
R. I. Sadykov, I. F. Akhtyamov, K. T. Shoshorina, S. A. Lapshina |
| |
| Vol 17, No 5 (2023) |
Efficacy and safety of long-term use of low molecular weight heparins in patients with systemic lupus erythematosus and antiphospholipid syndrome |
Abstract
PDF (Rus)
|
|
N. V. Seredavkina, F. A. Cheldieva, A. A. Shumilova, T. M. Reshetnyak |
| |
| Vol 17, No 5 (2023) |
Long-term results of therapy with sequential use of rituximab and belimumab in patients with systemic lupus erythematosus |
Abstract
PDF (Rus)
|
|
S. K. Solovyev, A. A. Mesnyankina, E. A. Aseeva, N. Yu. Nikishina |
| |
| Vol 17, No 5 (2023) |
Association of IRF5 (rs2004640), STAT4 (rs7574865), and TNFAIP3 (rs6920220, rs2230926) gene polymorphisms with primary Sjögren's syndrome and its complication, MALT-lymphoma |
Abstract
PDF (Rus)
|
|
I. A. Guseva, A. V. Torgashina, J. I. Khvan, M. Yu. Krylov, E. Yu. Samarkina, N. V. Konovalova, D. A. Varlamov |
| |
| Vol 17, No 5 (2023) |
Dynamics of global longitudinal strain of the left ventricular myocardium and blood biomarker levels in patients with rheumatoid arthritis treated with biologic disease-modifying antirheumatic drugs or Janus kinase inhibitors |
Abstract
PDF (Rus)
|
|
Yu. N. Gorbunova, I. G. Kirillova, T. V. Popkova, M. E. Diatroptov, T. I. Nevretdinov, A. M. Lila |
| |
| Vol 17, No 4 (2023) |
DNA double-strand breaks in immunoinflammatory rheumatic diseases |
Abstract
PDF (Rus)
|
|
A. S. Avdeeva, A. P. Aleksankin, Zh. G. Verizhnikova, V. V. Rybakova, M. E. Diatroptov, Yu. N. Gorbunova, A. A. Mesnyankina, D. A. Paranich, A. M. Lila, E. L. Nasonov |
| |
| Vol 17, No 4 (2023) |
Citrullinated histone H3 in systemic lupus erythematosus and antiphospholipid syndrome (preliminary results) |
Abstract
PDF (Rus)
|
|
K. S. Nurbaeva, T. M. Reshetnyak, M. V. Cherkasova, A. M. Lila |
| |
| Vol 17, No 4 (2023) |
Evaluation of the influence of polymorphisms of the transporter genes (RFC1, MDR1) and GGH on the efficacy of methotrexate in rheumatoid arthritis |
Abstract
PDF (Rus)
|
|
I. V. Devald, E. A. Hodus, D. Yu. Nokhrin, E. B. Khromova, G. L. Ignatova, D. S. Stashkevich, A. M. Lila, A. L. Burmistrova |
| |
| Vol 17, No 4 (2023) |
Efficacy of tumor necrosis factor-α inhibitors in the treatment of various immunoinflammatory diseases: focus on immunogenicity |
Abstract
PDF (Rus)
|
|
T. Yu. Nuriahmetova, I. Kh. Valeeva, Y. O. Shevnina, A. V. Petrov, N. A. Cheremina, E. V. Sukhorukova, A. G. Vasiliev, D. I. Abdulganieva |
| |
| Vol 17, No 4 (2023) |
Dystrophic calciphylaxis in panniculitis: features of the clinical picture and diagnosis |
Abstract
PDF (Rus)
|
|
O. N. Egorova, A. V. Datsina, M. V. Severinova |
| |
| 1 - 100 of 390 Items |
1 2 3 4 > >>
|
